346 related articles for article (PubMed ID: 26799159)
1. Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet.
Agamia NF; Abdallah DM; Sorour O; Mourad B; Younan DN
Br J Dermatol; 2016 Jun; 174(6):1299-307. PubMed ID: 26799159
[TBL] [Abstract][Full Text] [Related]
2. Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne.
Melnik BC; Zouboulis CC
Exp Dermatol; 2013 May; 22(5):311-5. PubMed ID: 23614736
[TBL] [Abstract][Full Text] [Related]
3. Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris.
Çerman AA; Aktaş E; Altunay İK; Arıcı JE; Tulunay A; Ozturk FY
J Am Acad Dermatol; 2016 Jul; 75(1):155-62. PubMed ID: 27061046
[TBL] [Abstract][Full Text] [Related]
4. Evidence for acne-promoting effects of milk and other insulinotropic dairy products.
Melnik BC
Nestle Nutr Workshop Ser Pediatr Program; 2011; 67():131-45. PubMed ID: 21335995
[TBL] [Abstract][Full Text] [Related]
5. Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro.
Mirdamadi Y; Thielitz A; Wiede A; Goihl A; Papakonstantinou E; Hartig R; Zouboulis CC; Reinhold D; Simeoni L; Bommhardt U; Quist S; Gollnick H
Mol Cell Endocrinol; 2015 Nov; 415():32-44. PubMed ID: 26257240
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum FoxO1, mTORC1, IGF-1, IGFBP-3 levels, and metabolic syndrome components in patients with acne vulgaris: A prospective case-control study.
Aktaş Karabay E; Saltık ZA; Unay Demirel Ö
Dermatol Ther; 2020 Nov; 33(6):e13887. PubMed ID: 32567791
[TBL] [Abstract][Full Text] [Related]
7. The role of transcription factor FoxO1 in the pathogenesis of acne vulgaris and the mode of isotretinoin action.
Melnik BC
G Ital Dermatol Venereol; 2010 Oct; 145(5):559-71. PubMed ID: 20930691
[TBL] [Abstract][Full Text] [Related]
8. The increase of mTOR expression is consistent with FoxO1 decrease at gene level in acne but not in psoriasis.
Lembo S; Di Caprio R; Balato A; Caiazzo G; Fabbrocini G; Skroza N; Tolino E; Potenza C
Arch Dermatol Res; 2020 Jan; 312(1):77-80. PubMed ID: 31367853
[No Abstract] [Full Text] [Related]
9. Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I.
Assaf HA; Abdel-Maged WM; Elsadek BE; Hassan MH; Adly MA; Ali SA
Dis Markers; 2016; 2016():7040312. PubMed ID: 27803511
[TBL] [Abstract][Full Text] [Related]
10. Association of insulin-like growth factor (IGF)-1 gene polymorphisms with plasma levels of IGF-1 and acne severity.
Rahaman SMA; De D; Handa S; Pal A; Sachdeva N; Ghosh T; Kamboj P
J Am Acad Dermatol; 2016 Oct; 75(4):768-773. PubMed ID: 27476104
[TBL] [Abstract][Full Text] [Related]
11. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris.
Melnik BC; Schmitz G
Exp Dermatol; 2009 Oct; 18(10):833-41. PubMed ID: 19709092
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components.
Wu AL; Kim JH; Zhang C; Unterman TG; Chen J
Endocrinology; 2008 Mar; 149(3):1407-14. PubMed ID: 18079193
[TBL] [Abstract][Full Text] [Related]
13. [Acne and diet].
Melnik BC
Hautarzt; 2013 Apr; 64(4):252, 254-8, 260-2. PubMed ID: 23529682
[TBL] [Abstract][Full Text] [Related]
14. Acne as an altered dermato-endocrine response problem.
Briganti S; Flori E; Mastrofrancesco A; Ottaviani M
Exp Dermatol; 2020 Sep; 29(9):833-839. PubMed ID: 32779245
[TBL] [Abstract][Full Text] [Related]
15. What's Diet Got to Do With It? Basic and Clinical Science Behind Diet and Acne.
Dodds M; Bodemer A; Shields BE
Cutis; 2022 Jul; 110(1):13-16. PubMed ID: 36179225
[TBL] [Abstract][Full Text] [Related]
16. Body mass index, selected dietary factors, and acne severity: are they related to in situ expression of insulin-like growth factor-1?
Seleit I; Bakry OA; Abdou AG; Hashim A
Anal Quant Cytopathol Histpathol; 2014 Oct; 36(5):267-78. PubMed ID: 25803999
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin.
Monfrecola G; Lembo S; Caiazzo G; De Vita V; Di Caprio R; Balato A; Fabbrocini G
Exp Dermatol; 2016 Feb; 25(2):153-5. PubMed ID: 26477999
[No Abstract] [Full Text] [Related]
18. FoxO1 - the key for the pathogenesis and therapy of acne?
Melnik BC
J Dtsch Dermatol Ges; 2010 Feb; 8(2):105-14. PubMed ID: 20151947
[TBL] [Abstract][Full Text] [Related]
19. A Study of FoxO1, mTOR, miR-21, miR-29b, and miR-98 Expression Levels Regarding Metabolic Syndrome in Acne Vulgaris Patients.
Akdağ N; Atli E; Zhuri D; Sezgi Ner Güler H; Gürsel Ürün Y
Cureus; 2024 Mar; 16(3):e56562. PubMed ID: 38646331
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 promotes growth of gastric cancer by inhibiting foxo1 nuclear retention.
Li S; Lei X; Zhang J; Yang H; Liu J; Xu C
Tumour Biol; 2015 Jun; 36(6):4519-23. PubMed ID: 25596089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
